Navigation Links
Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
Date:12/7/2009

the Oralair(R) program as a whole, which remain extremely consistent. The development program, which focuses on the benefit to patients and fits squarely with current cost-containment trends, confirms the relevance of Stallergenes' strategic choices.

Our 2009 clinical news flow has been very dense and is not over yet. There are still more results to come and more analyses to be conducted. We will be delighted to present all these findings at an R&D day to be held at the start of 2010." says Albert Saporta, Chairman and CEO of Stallergenes.

ABOUT ORALAIR(R)

The Oralair(R) clinical development program has demonstrated the short-term efficacy of the product at an appropriate dose of 300 IR during the first season, through two clinical studies in adults and children (VO34.04 and VO52.06).

Through a pharmacodynamics study (V056.07), Stallergenes demonstrated that its immunotherapy tablet had an effect on symptoms from the very first month of treatment, without the use of rescue medication and irrespective of variable patient exposure to pollen.

The Oralair(R) development program, which has so far included over 1,800 patients, makes the level of clinical evidence for this treatment indisputable. This program, which was initiated in 2003 and is fully in line with EMEA guidelines issued in 2008, will help immunotherapy tablets achieve the same level of recognition as conventional pharmaceuticals.

From the outset, the Oralair(R) clinical development program has addressed the key issues involved in grass pollen immunotherapy:

    - It answers the unmet needs of patients suffering from severe
      rhino-conjunctivitis caused by grass pollen, inadequately controlled
      using symptomatic treatments,

    - It favors compliance and cost-containment, through its pre-
      and coseasonal protocol (the treatment is taken for four months prior
      to the pollen seaso
'/>"/>
SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
2. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
4. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
5. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
6. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
7. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
8. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
9. Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction/Positive BPH Results
10. Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
11. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... MOUNTAIN VIEW, Calif. , May 28, 2015 ... healthcare informatics market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Company of the ... effort to take HCM to the next level ... highly strategic acquisitions and followed them up with ...
(Date:5/28/2015)... -- Cardinal Health today announced that its March 1, 2015 ... for $1.944 billion in cash was formally accepted.  The ... and trade unions. The transaction is expected to close ... key non-U.S. countries towards the end of 2015, subject ... Headquartered in Fremont, Calif. , ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, announced today the launch ... Campaign for its Precision Cancer Monitoring SM ... Oncology Annual Meeting. The campaign will center on ... can gain hands on clinical experience with the ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 2Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 3Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting 4
... Boston Scientific Corporation (NYSE: BSX ) ... quality of life outcomes, based on one-year data from ... while the overall cost effectiveness of percutaneous coronary intervention ... according to patient characteristics, PCI was more cost effective ...
... to be presented at Israel Society of ... reach 5 months from single treatment - Data ... scores of expensive injections MISGAV, Israel and LONDON, March ... that the latest, encouraging results of the Company,s ongoing ...
Cached Medicine Technology:SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 2SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 3SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 4SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease 5Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 2Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 3Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients 4
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Khanna ... interactive keratoconus web application to make learning about ... in the last few years. This proliferation of treatment ... are not aware of the nuances of the cutting ... Institute, realized that websites can be boring and printed ...
(Date:5/28/2015)... May 28, 2015 Sexual Health ... that advances sexual health and wellbeing in the ... of San Francisco (USF) will be the first ... assault recording and reporting system. , Callisto ... and confidential reporting experience for college sexual assault ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Optimity ... and implementing innovative models of care for healthcare ... support alternative reimbursements and help operationalize contracting and ... also unveils a bi-weekly series of seven “ ... Outcomes Based Contracting. Optimity is a strategy, operations ...
(Date:5/28/2015)... Cancer survivors who participated in the ... activity, fitness and quality of life, according to research ... and Jennifer Ligibel, MD, senior physician in the Susan ... Institute. The findings will be presented at this year’s ... Meeting in Chicago. , The study, designed ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
Breaking Medicine News(10 mins):Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3
... national study of escalator-related injuries to older adults, researchers ... Dr.PH., MPH, of the Indiana University School of Medicine, ... from 1991 to 2005. The results of the study ... journal Accident Analysis and Prevention. , Using U.S. Consumer ...
... FALL RIVER, Mass., March 13 Millstone ... signed agreements,with four companies to provide loaner ... facility, which opened in October 2007.,Two of ... Innovative Spinal Technologies, Inc. and OMNI life ...
... to Ease the Process for Physicians to Select Electronic ... Ohio State,Medical Association (OSMA) announced that it is launching ... its kind, to help reduce the risk for,physicians who ... for,their practices., The Standards of Excellence Program, which ...
... on Restorative Options, HARRISBURG, Pa., March 13 ... PDA member dentists use a recently,published brochure by ... with patients., "The Pennsylvania Dental Association encourages ... oral health issues," said Dr. Jon J.,Johnston, President ...
... study at the University of Texas Medical Branch at ... most common diseases of young children: colds and ear ... 15 issue of Clinical Infectious Disease, confirmed the suspected ... young children, viral colds and ear infections. It also ...
... Mich. A commonly used medication that prevents blood ... damaging delicate vein walls and may accelerate healing ... new research from the University of Michigan Cardiovascular Center. ... more evidence to support the aggressive anti-clot efforts now ...
Cached Medicine News:Health News:Rate of escalator injuries to older adults has doubled 2Health News:Customers Take Advantage of Loaner Kit Processing Services at Millstone Medical Outsourcing's Memphis Facility 2Health News:Customers Take Advantage of Loaner Kit Processing Services at Millstone Medical Outsourcing's Memphis Facility 3Health News:OSMA Launches EMR Standards of Excellence Program 2Health News:OSMA Launches EMR Standards of Excellence Program 3Health News:OSMA Launches EMR Standards of Excellence Program 4Health News:OSMA Launches EMR Standards of Excellence Program 5Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2Health News:Researchers confirm link between common cold and ear infection 2Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 2Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 3Health News:Damaged veins heal faster with heparin treatment, laboratory study finds 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: